- |||||||||| Trial completion, Enrollment change, Trial primary completion date: WSRIT: Response Inhibition Training for Children With Williams Syndrome (clinicaltrials.gov) - May 31, 2017
P=N/A, N=25, Completed, N=12 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Jan 2018 --> Jun 2017 Recruiting --> Completed | N=20 --> 25 | Trial primary completion date: Dec 2015 --> May 2016
- |||||||||| Trial completion, Trial initiation date, Trial primary completion date: Frequency of Metabolic Syndrome in Down Syndrome Patients (clinicaltrials.gov) - May 5, 2017
P=N/A, N=96, Completed, Trial primary completion date: Jul 2017 --> Dec 2017 Not yet recruiting --> Completed | Initiation date: May 2009 --> Sep 2009 | Trial primary completion date: May 2009 --> Dec 2009
- |||||||||| Biomarker, Trial completion, Trial primary completion date: Down Syndrome Biomarker Initiative (DSBI) (clinicaltrials.gov) - May 2, 2017
P=N/A, N=12, Completed, Not yet recruiting --> Completed | Initiation date: May 2009 --> Sep 2009 | Trial primary completion date: May 2009 --> Dec 2009 Active, not recruiting --> Completed | Trial primary completion date: Jan 2017 --> Apr 2017
- |||||||||| Trial completion, Enrollment change, Trial initiation date: Decisional Capacity and Informed Consent in Fragile X Syndrome (clinicaltrials.gov) - Apr 17, 2017
P=N/A, N=156, Completed, Active, not recruiting --> Completed | Trial primary completion date: Jan 2017 --> Apr 2017 Recruiting --> Completed | N=200 --> 156 | Initiation date: Oct 2015 --> Mar 2016
- |||||||||| Trial completion, Enrollment change, Trial primary completion date: Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes (clinicaltrials.gov) - Mar 15, 2017
P=N/A, N=20, Completed, Active, not recruiting --> Completed | N=100 --> 11 | Trial primary completion date: Nov 2016 --> Dec 2015 Recruiting --> Completed | N=100 --> 20 | Trial primary completion date: Oct 2016 --> Jul 2016
- |||||||||| Norditropin (somatropin) / Novo Nordisk
Trial completion, Enrollment change: Observational Prospective Study on Patients Treated With Norditropin® (clinicaltrials.gov) - Feb 6, 2017 P=N/A, N=21249, Completed, Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2017 --> Dec 2016 Enrolling by invitation --> Completed | N=17000 --> 21249
- |||||||||| Trial completion, Enrollment change, Trial primary completion date: Prader-Willi Syndrome Macronutrient Study (clinicaltrials.gov) - Dec 14, 2016
P=N/A, N=10, Completed, Active, not recruiting --> Terminated; FDA Clinical Hold Recruiting --> Completed | N=13 --> 10 | Trial primary completion date: Sep 2016 --> May 2016
- |||||||||| Enrollment closed, Enrollment change: Natural History of Amyloid Deposition in Adults With Down Syndrome (clinicaltrials.gov) - Nov 2, 2016
P=N/A, N=81, Active, not recruiting, Active, not recruiting --> Completed | Trial primary completion date: Nov 2016 --> May 2016 Recruiting --> Active, not recruiting | N=64 --> 81
- |||||||||| Trial completion, Enrollment change: Subcapsular Orchiectomy in Men With Klinefelter Syndrome (clinicaltrials.gov) - Oct 4, 2016
P=N/A, N=14, Completed, Active, not recruiting --> Completed | Trial primary completion date: Feb 2014 --> Apr 2015 Recruiting --> Completed | N=20 --> 14
- |||||||||| Byetta (exenatide) / AstraZeneca
Trial completion, Enrollment change: Effects of Exenatide on Overweight Adolescents With Prader-Willi Syndrome (clinicaltrials.gov) - Sep 29, 2016 P=N/A, N=10, Completed, Enrolling by invitation --> Active, not recruiting | Trial primary completion date: Jun 2016 --> Nov 2016 Active, not recruiting --> Completed | N=20 --> 10
- |||||||||| Enrollment closed, Preclinical, Trial primary completion date: DEPOSA: T21,18 and 13 Screening by Cell Free Fetal DNA in Low Risk Patients (clinicaltrials.gov) - Sep 29, 2016
P=N/A, N=933, Active, not recruiting, Active, not recruiting --> Completed | N=20 --> 10 Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2016 --> Sep 2016
- |||||||||| Trial completion, Enrollment change, Trial primary completion date: Pregnancy Chances in Classic Galactosemia (clinicaltrials.gov) - Sep 13, 2016
P=N/A, N=85, Completed, Not yet recruiting --> Recruiting Recruiting --> Completed | N=150 --> 85 | Trial primary completion date: Dec 2015 --> Sep 2016
|